Adhesion-GPCRs in tumorigenesis

Advances in Experimental Medicine and Biology

Volumn 706, Issue , 2010, Pages 109-120

  Aust, Gabriela ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD97 ANTIGEN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 111; G PROTEIN COUPLED RECEPTOR 112; G PROTEIN COUPLED RECEPTOR 113; G PROTEIN COUPLED RECEPTOR 115; G PROTEIN COUPLED RECEPTOR 116; G PROTEIN COUPLED RECEPTOR 123; G PROTEIN COUPLED RECEPTOR 124; G PROTEIN COUPLED RECEPTOR 125; G PROTEIN COUPLED RECEPTOR 133; G PROTEIN COUPLED RECEPTOR 144; G PROTEIN COUPLED RECEPTOR 56; G PROTEIN COUPLED RECEPTOR 64; G PROTEIN COUPLED RECEPTOR 97; LATROPHILIN 1; LATROPHILIN 2; LATROPHILIN 3; MEMBRANE PROTEIN; PROTEIN BAI1; PROTEIN BAI2; PROTEIN BAI3; PROTEIN CELSR1; PROTEIN CELSR2; PROTEIN CELSR3; PROTEIN EMR1; PROTEIN EMR2; PROTEIN EMR3; PROTEIN EMR4; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CYTOGENETICS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GLYCOSYLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR GROWTH;

ANIMALS; CELL COMMUNICATION; DATABASES, FACTUAL; HUMANS; NEOPLASMS; PROTEIN ISOFORMS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 79960810137     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7913-1_9     Document Type: Article

References (49)

1. BioGPS; http://biogps.gnf; 2009.
2. Human Protein Atlas (HPA); http://www.proteinatlas.org; 2009.
3. Atlas of Genetics and Cytogenetics in Oncology and Haematology (AGCOH); http://atlasgeneticsoncology. org; 2009.
4. Bjarnadottir TK, Fredriksson R, Schioth HB. The adhesion-GPCRs: A unique family of G protein-coupled receptors with important roles in both central and peripheral tissues. Cell Mol Life Sci 2007; 64:2104-2119. (Pubitemid 350092419)
5. Ichtchenko K, Bittner MA, Krasnoperov V et al. A novel ubiquitously expressed alpha-latrotoxin receptor is a member of the CIRL family of G-protein-coupled receptors. J Biol Chem 1999; 274:5491-5498. (Pubitemid 29109196)
6. Matsushita H, Lelianova VG, Ushkaryov YA. The latrophilin family: Multiply spliced G protein-coupled receptors with differential tissue distribution. FEBS Lett 1999; 443:348-352. (Pubitemid 29080824)
7. Sudhof TC. Alpha-latrotoxin and its receptors: Neurexins and CIRL/latrophilins. Annu Rev Neurosci 2001; 24:933-962. (Pubitemid 32695249)
8. White GR, Varley JM, Heighway J. Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31.1 implicated in breast cancer. Oncogene 1998; 17:3513-3519. (Pubitemid 29050687)
9. White GR, Varley JM, Heighway J. Genomic structure and expression profile of LPHH1, a 7TM gene variably expressed in breast cancer cell lines. Biochim Biophys Acta 2000; 1491:75-92. (Pubitemid 30173335)
10. Jaspars LH, Vos W, Aust G et al. Tissue distribution of the human CD97 EGF-TM7 receptor. Tissue Antigens 2001; 57:325-331. (Pubitemid 32511301)
11. Aust G, Wandel E, Boltze C et al. Diversity of CD97 in smooth muscle cells (SMCs). Cell Tissue Res 2006; 323:1-9.
12. Wobus M, Vogel B, Schmücking E et al. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding. Int J Cancer 2004; 112:815-822. (Pubitemid 39435266)
13. Aust G. Immunohistochemical detection of CD97 in colorectal carcinomas. In: Hayat MA, ed. Immunohistochemistry and in situ hybridization of human carcinomas. Burlington, San Diego, London: Elsevier Academic Press, 2005:201-206.
14. Aust G, Eichler W, Laue S et al. CD97: A dedifferentiation marker in human thyroid carcinomas. Cancer Res 1997; 57:1798-1806. (Pubitemid 27199676)
15. Boltze C, Schneider-Stock R, Aust G et al. CD97, CD95 and Fas-L clearly discriminate between chronic pancreatitis and pancreatic ductal adenocarcinoma in perioperative evaluation of cryocut sections. Pathol Int 2002; 52:83-88. (Pubitemid 34298094)
16. Hamann J, Vogel B, van Schijndel GM et al. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 1996; 184:1185-1189. (Pubitemid 26313577)
17. Hoang-Vu C, Bull K, Schwarz I et al. Regulation of CD97 protein in thyroid carcinoma. J Clin Endocrinol Metab 1999; 84:1104-1109. (Pubitemid 29138250)
18. Steinert M, Wobus M, Boltze C et al. Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Am JPathol 2002; 161:1657-1667. (Pubitemid 35265525)
19. Aust G, Steinert M, Schütz A et al. CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic and esophageal carcinomas. Am J Clin Pathol 2002; 118:699-707. (Pubitemid 37046314)
20. Galle J, Sittig D, Hanisch I et al. Individual cell-based models of tumor-environment interactions. Multiple effects of CD97 on tumor invasion. Am J Pathol 2006; 169:1802-1811. (Pubitemid 351182009)
21. Hamann J, Wishaupt JO, van Lier RA et al. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum 1999; 42:650-658. (Pubitemid 29171984)
22. Wang T, Ward Y, Tian L et al. CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counter receptors on endothelial cells. Blood 2004; 105:2836-2844. (Pubitemid 40446277)
23. Aust G, Hamann J, Schilling N et al. Detection of alternatively spliced EMR2 mRNAs in colorectal tumor cell lines but rare expression of the molecule in the corresponding adenocarcinomas. Virchows Arch 2003; 443:32-37. (Pubitemid 36920948)
24. Lin HH, Stacey M, Hamann J et al. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p1 3.1, is closely related to CD97. Genomics 2000; 67:188-200. (Pubitemid 30614587)
25. Lagerstrom MC, Rabe N, Haitina T et al. The evolutionary history and tissue mapping of GPR123: Specific CNS expression pattern predominantly in thalamic nuclei and regions containing large pyramidal cells. JNeurochem2007; 100:1129-1142. (Pubitemid 46213935)
26. Carson-Walter EB, Watkins DN, Nanda A et al. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001; 61:6649-6655. (Pubitemid 32896479)
27. Vallon M, Essler M. Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha(v)beta3 to glycosaminoglycans. JBiolChem 2006; 281:34179-34188. (Pubitemid 46036626)
28. Pickering C, Hagglund M, Szmydynger-Chodobska J et al. The Adhesion GPCR GPR125 is specifically expressed in the choroid plexus and is upregulated following brain injury. BMC Neurosci 2008; 9:97.
29. Katoh M, Katoh M. Comparative integromics on noncanonical WNT or planar cell polarity signaling molecules: Transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6 A in undifferentiated ES cells. Int J Mol Med 2007; 20:405-409.
30. Kaur B, Brat DJ, Calkins CC et al. Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression. Am J Pathol 2003; 162:19-27. (Pubitemid 36041986)
31. Kee HJ, Ahn KY, Choi KC et al. Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma. FEBS Lett 2004; 569:307-316. (Pubitemid 38844637)
32. Mori K, Kanemura Y, Fujikawa H et al. Brain-specific angiogenesis inhibitor 1 (BAH) is expressed in human cerebral neuronal cells. Neurosci Res 2002; 43:69-74. (Pubitemid 34628584)
33. Nishimori H, Shiratsuchi T, Urano T et al. A novel brain-specific p53-target gene, BAH, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 1997; 15:2145-2150. (Pubitemid 27493903)
34. Koh JT, Kook H, Kee HJ et al. Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking alphavbeta5 integrin. Exp Cell Res 2004; 294:172-184. (Pubitemid 38232664)
35. Kaur B, Brat DJ, Devi NS et al. Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor. Oncogene 2005; 24:3632-3642. (Pubitemid 40756232)
36. Kudo S, Konda R, Obara W et al. Inhibition of tumor growth through suppression of angiogenesis by brain-specific angiogenesis inhibitor 1 gene transfer in murine renal cell carcinoma. Oncol Rep 2007; 18:785-791.
37. Kang X, Xiao X, Harata M et al. K. Antiangiogenic activity of BAI1 in vivo: Implications for gene therapy of human glioblastomas. Cancer Gene Ther2006; 13:385-392.
38. Zendman AJ, Cornelissen IM, Weidle UH et al. TM7XN1, anovel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential. FEBS Lett 1999; 446:292-298. (Pubitemid 29132746)
39. Jin Z, Tietjen I, Bu L et al. Disease-associated mutations affect GPR56 protein trafficking and cell surface expression. Hum Mol Genet 2007; 16:1972-1985. (Pubitemid 47354880)
40. Piao X, Hill RS, Bodell A et al. G protein-coupled receptor-dependent development of human frontal cortex. Science 2004; 303:2033-2036. (Pubitemid 38393281)
41. Huang Y, Fan J, Yang J et al. Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells. Mol Cell Biochem 2008; 308:133-139. (Pubitemid 351167854)
42. Xu L, Begum S, Hearn JD et al. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2 and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci USA 2006; 103:9023-9028. (Pubitemid 43902526)
43. Xu, L, Hynes Ro. GPR56 and TgG2 possible roles in suppression of tumor growth by the microenvironment. Cell Cycle 2007; 6:760-765.
44. Jones RA, Kotsakis P, Johnson TS et al. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 2006; 13:1442-1453. (Pubitemid 44210348)
45. Shashidhar S, Lorente G, Nagavarapu U et al. GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 2005; 24:1673-1682. (Pubitemid 40461124)
46. Ke N, Sundaram R, Liu G et al. Orphan G protein-coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway. Mol Cancer Ther 2007; 6:1840-1850. (Pubitemid 46954061)
47. Kim JE, Han JM, Park CR et al. Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis. J Cancer Res Clin Oncol 2009.
48. Obermann H, Samalecos A, Osterhoff C et al. HE6, a two-subunit heptahelical receptor associated with apical membranes of efferent and epididymal duct epithelia. Mol Reprod Dev 2003; 64:13-26. (Pubitemid 35398483)
49. Fredriksson R, Lagerstrom MC, Hoglund PJ et al. Novel human G protein-coupled receptors with long N-terminals containing GPS domains and Ser/Thr-rich regions. FEBS Lett 2002; 531:407-414. (Pubitemid 35336060)